10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026)

10x Genomics (TXG) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 31.95%
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -1,545.42%
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -23.22%
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 50.05%
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -28.47%
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Privia Health 2.78 Bn 2.42 Bn - -45.66%

Historic Data

Download Data
DateValue
Jun 30, 2026 50.05%
Mar 31, 2026 -47.37%
Dec 31, 2025 69.30%
Sep 30, 2025 42.15%
Jun 30, 2025 36.30%
Mar 31, 2025 28.45%
Dec 31, 2024 -60.95%
Sep 30, 2024 34.94%
Jun 30, 2024 71.77%
Mar 31, 2024 57.46%
Dec 31, 2023 32.14%
Sep 30, 2023 -26.77%
Jun 30, 2023 31.94%
Mar 31, 2023 65.43%
Dec 31, 2022 -144.54%
Sep 30, 2022 -27.98%
Jun 30, 2022 -56.64%
Mar 31, 2022 -582.37%
Dec 31, 2021 10.40%